-
-
-
VIVOZON Pharmaceutical Obtains MFDS Approval for UNAFRA Inj.: A Breakthrough Non-Opioid analgesic
SEOUL,South Korea,Feb. 18,2025-- On February 17,VIVOZON Pharmaceutical announced that its non-opioid analgesic,UNAFRA Inj.,was approved on December 12,2024. (active ingredient: Opiranserin HCl),has r
VIVOZON Pharmaceutical / 02-19
-
-
-
-
OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination
OSR Holdings,Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday,February 18,2025 Under the symbol "OSRH"
-
-
-
-
Five USANA Country/Region Markets Recognized for Product Excellence by Euromonitor International
USANA Malaysia,Philippines,Singapore,Taiwanand Hong Kongregion all awarded KUALA LUMPUR,Malaysia,Feb. 15,2025-- Five of USANA Health Sciences\' Asia Pacific markets were recently awarded by the prest
USANA / 02-18
-
-
-
-
Vitafoods India 2025: Angel Yeast Brings Innovative Yeast Protein to Dining Table
MUMBAI,India,Feb. 17,2025-- Angel Yeast (SH600298),a global leader in yeast manufacturing,has recently showcased its revolutionary yeast protein solutions and products at the 2025 Vitafoods India whi
Angel Yeast / 02-18
-
-
-
-
Pre-order Centauri Carbon Now: Elegoo's First Core-XY 3D Printer for Reliability in Creativity
SHENZHEN,China,Feb. 17,2025-- Elegoo,a rapidly developing brand in global smart manufacturing,officially launches pre-orders today for its first Core-XY 3D printer,built for top reliability to boost
ELEGOO Inc / 02-18
-
-
-
-
LONGi maintains AAA ranking in Q4 2024 PV ModuleTech Bankability Ratings
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
-
-
-
-
Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu
-
-
-
-
LambdaTest unveils 2024 Partner of the Year Award winners
LambdaTest Partner Awards 2024 honors the top partners globally for their contributions to quality engineering and innovation.
-
-
-
-
Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
Kexing Biopharm / 02-17
-
-
-
-
OneConnect Integrates DeepSeek into AI Agent Platform
SHANGHAI,Feb. 13,2025-- OneConnect Financial Technology Co.,Ltd ("OneConnect" or the "Company",NYSE: OCFT,HKSE: 6638),a business technology service provider for financial instituti
-
Travelling guideline
Newest
